LIN SHAO-LEE (CHIEF EXECUTIVE OFFICER) sold 7.6% of their position (58.26K shares) of CUE BIOPHARMA, INC. on the open market
Open‑market sale worth $1.61M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+109.18K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−34.23K
Price / share
$26.99
Trade value
$923.73K
% of position
Common Stock
Shares
−5.78K
Price / share
$27.75
Trade value
$160.26K
% of position
Common Stock
Shares
−5.42K
Price / share
$27.19
Trade value
$147.45K
% of position
Common Stock
Shares
−2.38K
Price / share
$28.11
Trade value
$66.76K
% of position
Common Stock
Shares
−10.46K
Price / share
$29.48
Trade value
$308.36K
% of position
Net shares
+50.92K
Net value
-$1.61M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2026 | M · Option Exercise | +109.18K | — | — | 16.7% | 655.07K | 764.25K |
| Common Stock Direct | 8/12/2026 | S · Sale | −34.23K | $26.99 | $923.73K | 4.5% | 764.25K | 730.03K |
| Common Stock Direct | 8/12/2026 | S · Sale | −5.78K | $27.75 | $160.26K | 0.8% | 730.03K | 724.25K |
| Common Stock Direct | 8/13/2026 | S · Sale | −5.42K | $27.19 | $147.45K | 0.7% | 724.25K | 718.83K |
| Common Stock Direct | 8/13/2026 | S · Sale | −2.38K | $28.11 | $66.76K | 0.3% | 718.83K | 716.46K |
| Common Stock Direct | 8/13/2026 | S · Sale | −10.46K | $29.48 | $308.36K | 1.5% | 716.46K | 706K |
| Total | +50.92K | -$1.61M | ||||||
Common Stock
Common Stock
109.18K shares
Shares
−109.18K
Strike price
Held after
218.36K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Direct | Common Stock109.18K shares | 8/12/2026 | M · Option Exercise | −109.18K | — | 218.36K |